Alliancebernstein L.P. raised its holdings in shares of Wright Medical Group NV (NASDAQ:WMGI) by 48.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 556,409 shares of the medical device company’s stock after purchasing an additional 180,334 shares during the quarter. Alliancebernstein L.P. owned 0.52% of Wright Medical Group worth $16,147,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Swiss National Bank grew its position in Wright Medical Group by 17.3% during the third quarter. Swiss National Bank now owns 203,394 shares of the medical device company’s stock valued at $5,902,000 after buying an additional 30,000 shares during the period. Tygh Capital Management Inc. grew its position in Wright Medical Group by 43.1% during the third quarter. Tygh Capital Management Inc. now owns 345,986 shares of the medical device company’s stock valued at $10,041,000 after buying an additional 104,211 shares during the period. Rhumbline Advisers grew its position in Wright Medical Group by 7.0% during the third quarter. Rhumbline Advisers now owns 106,811 shares of the medical device company’s stock valued at $3,100,000 after buying an additional 7,028 shares during the period. Parametrica Management Ltd bought a new position in Wright Medical Group during the third quarter valued at about $204,000. Finally, Los Angeles Capital Management & Equity Research Inc. grew its position in Wright Medical Group by 378.1% during the third quarter. Los Angeles Capital Management & Equity Research Inc. now owns 66,644 shares of the medical device company’s stock valued at $1,934,000 after buying an additional 52,704 shares during the period.

In other news, insider Peter Cooke sold 20,662 shares of the stock in a transaction dated Thursday, November 8th. The shares were sold at an average price of $29.28, for a total value of $604,983.36. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Elizabeth H. Weatherman sold 15,949 shares of the stock in a transaction dated Monday, November 19th. The stock was sold at an average price of $28.63, for a total transaction of $456,619.87. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 67,466 shares of company stock worth $1,962,392. Insiders own 4.00% of the company’s stock.

Several research firms recently weighed in on WMGI. BMO Capital Markets upgraded shares of Wright Medical Group from a “market perform” rating to an “outperform” rating and increased their price target for the company from $28.00 to $31.00 in a research report on Wednesday, August 29th. Cantor Fitzgerald increased their price target on shares of Wright Medical Group from $30.00 to $35.00 and gave the company an “overweight” rating in a research report on Thursday, August 9th. Piper Jaffray Companies increased their price target on shares of Wright Medical Group to $32.00 and gave the company an “overweight” rating in a research report on Thursday, August 9th. Oppenheimer set a $28.00 price target on shares of Wright Medical Group and gave the company a “hold” rating in a research report on Thursday, August 9th. Finally, Jefferies Financial Group increased their price target on shares of Wright Medical Group from $28.00 to $30.00 and gave the company a “buy” rating in a research report on Thursday, August 9th. Three research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $32.62.

NASDAQ WMGI opened at $27.34 on Thursday. The stock has a market cap of $3.50 billion, a price-to-earnings ratio of -124.27 and a beta of 1.15. Wright Medical Group NV has a 52 week low of $19.01 and a 52 week high of $30.75. The company has a current ratio of 1.24, a quick ratio of 1.07 and a debt-to-equity ratio of 0.61.

Wright Medical Group (NASDAQ:WMGI) last released its quarterly earnings data on Wednesday, November 7th. The medical device company reported ($0.09) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.15) by $0.06. The business had revenue of $194.11 million for the quarter, compared to the consensus estimate of $186.09 million. Wright Medical Group had a negative net margin of 13.07% and a negative return on equity of 0.60%. The company’s revenue was up 13.8% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.16) earnings per share. On average, analysts anticipate that Wright Medical Group NV will post -0.07 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This news story was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international copyright laws. The correct version of this news story can be viewed at https://www.watchlistnews.com/alliancebernstein-l-p-grows-position-in-wright-medical-group-nv-wmgi/2663672.html.

Wright Medical Group Company Profile

Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells extremities and biologics products. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.

Further Reading: How a Put Option Works

Institutional Ownership by Quarter for Wright Medical Group (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.